Point-of-care monitoring of haemostasis

Anaesthesia

Volumn 70, Issue S1, 2015, Pages 73-77

  Mallett, S V ^a   Armstrong, M ^a  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING TEST; BLOOD TRANSFUSION; HEART SURGERY; HEMOSTASIS; HOSPITAL INFORMATION SYSTEM; HUMAN; LIVER TRANSPLANTATION; POSTPARTUM HEMORRHAGE;

BLOOD COAGULATION TESTS; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; HEMOSTASIS; HUMANS; LIVER TRANSPLANTATION; POINT-OF-CARE SYSTEMS; POSTPARTUM HEMORRHAGE;

EID: 84925226178     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/ANAE.12909     Document Type: Review

References (64)

1. Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096–101.
2. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. European Journal of Anaesthesiology 2013; 30: 270–82.
3. Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood 2010; 116: 878–85.
4. Goodnough LT, Shander A. Patient blood management. Anesthesiology 2012; 116: 1367–76.
5. Afshari A, Wikkelso A, Brok J, Moller AM, Wetterslev J. Throm-belastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database of Systematic Reviews 2011; 3: CD007871.
6. Avidan MS, Alcock EL, Da Fonseca J, et al. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. British Journal of Anaesthesia 2004; 92: 178–86.
7. Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ. Guidelines on the management of massive blood loss. British Journal of Haematology 2006; 135: 634–41.
8. Segal JB, Dzik WH. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 2005; 45: 1413–25.
9. Hoffman M, Monroe DM. A cell-based model of hemosta-sis. Thrombosis and Haemostasis 2001; 85: 958–65.
10. Mann KG. Thrombin formation. Chest 2003; 124: 4S–10S.
11. Snyder-Ramos SA, Mohnle P, Weng YS, et al. The ongoing var-iability in blood transfusion practices in cardiac surgery. Transfusion 2008; 48: 1284–99.
12. Bennett-Guerrero E, Zhao Y, O’Brien SM, et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. Journal of the American Medical Association 2010; 304: 1568–75.
13. Ozier Y, Pessione F, Samain E, Courtois F. Institutional variabil-ity in transfusion practice for liver transplantation. Anesthesia and Analgesia 2003; 97: 671–9.
14. Likosky DS, FitzGerald DC, Groom RC, et al. Effect of the perioperative blood transfusion and blood conservation in cardiac surgery clinical practice guidelines of the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists upon clinical practices. Anesthesia and Analgesia 2010; 111: 316–23.
15. Spiess BD. Blood management-issues: the panic of coagulo-pathic bleeding-is there a rational approach? Journal of Extra-corporeal Technology 2011; 43: 58–64.
16. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Ange-lini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac sur-gery. Circulation 2007; 16: 544–52.
17. Stokes ME, Ye X, Shah M, et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Services Research 2011; 11: 135.
18. Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guide-lines. The Annals of Thoracic Surgery 2011; 91: 944–82.
19. Toulon P, Ozier Y, Ankri A, Fleron MH, Leroux G, Samama CM. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. Thrombosis and Haemostasis 2009; 101: 394–401.
20. Meesters MI, Vonk AB, van de Weerdt EK, Kamminga S, Boer C. Level of agreement between laboratory and point-of-care prothrombin time before and after cardiopulmonary bypass in cardiac surgery. Thrombosis Research 2014; 133: 1141–4.
21. Amukele TK, Ferrell C, Chandler WL. Comparison of plasma with whole blood prothrombin time and fibrinogen on the same instrument. American Journal of Clinical Pathology 2010; 133: 550–6.
22. Gauss T, Hamada S, Jurcisin I, et al. Limits of agreement between measures obtained from standard laboratory and the point-of-care device Hemochron Signature Elite(R) during acute haemorrhage. British Journal of Anaesthesia 2014; 112: 514–20.
23. Despotis GJ, Santoro SA, Spitznagel E, et al. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. Journal of Thoracic and Cardiovascular Surgery 1994; 107: 271–9.
24. Nuttall GA, Oliver WC, Santrach PJ, et al. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 2001; 94: 773–81.
25. Magnotti LJ, Zarzaur BL, Fischer PE, et al. Improved survival after hemostatic resuscitation: does the emperor have no clothes? Journal of Trauma 2011; 70: 97–102.
26. Davenport R, Khan S. Management of major trauma haemor-rhage: treatment priorities and controversies. British Journal of Haematology 2011; 155: 537–48.
27. Kashuk JL, Moore EE, Sawyer M, et al. Postinjury coagulopathy management: goal directed resuscitation via POC thrombelas-tography. Annals of Surgery 2010; 251: 604–14.
28. Spalding GJ, Hartrumpf M, Sierig T, Oesberg N, Kirschke CG, Albes JM. Cost reduction of perioperative coagulation management in cardiac surgery: value of ‘‘bedside’’ thrombelastography (ROTEM). European Journal of Cardiotho-racic Surgery 2007; 31: 1052–7.
29. Spiess BD, Gillies BS, Chandler W, Verrier E. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. Journal of Cardiothoracic and Vascular Anesthesia 1995; 9: 168– 73.
30. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesthesia and Analgesia 2008; 106: 1366–75.
31. Whiting D, DiNardo JA. TEG and ROTEM: technology and clinical applications. American Journal of Hematology 2014; 89: 228– 32.
32. Kashuk JL, Moore EE, Sabel A, et al. Rapid thrombelastogra-phy (r-TEG) identifies hypercoagulability and predicts throm-boembolic events in surgical patients. Surgery 2009; 146: 764–74.
33. Coakley M, Reddy K, Mackie I, Mallett S. Transfusion triggers in orthotopic liver transplantation: a comparison of the throm-boelastometry analyzer, the thromboelastogram, and conven-tional coagulation tests. Journal of Cardiothoracic and Vascular Anesthesia 2006; 20: 548–53.
34. Nielsen VG. A comparison of the Thrombelastograph and the ROTEM. Blood Coagulation and Fibrinolysis 2007; 18: 247–52.
35. Ak K, Isbir CS, Tetik S, et al. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. Journal of Cardiac Surgery 2009; 24: 404–10.
36. Girdauskas E, Kempfert J, Kuntze T, et al. Thromboelasto-metrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial. Journal of Thoracic and Cardiovascular Surgery 2010; 140: 1117–24.
37. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesthesia and Analgesia 1999; 88: 312–9.
38. Weber CF, Gorlinger K, Meininger D, et al. Point-of-care test-ing: a prospective, randomized clinical trial of efficacy in coag-ulopathic cardiac surgery patients. Anesthesiology 2012; 117: 531–47.
39. Levy JH, Welsby I, Goodnough LT. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion 2014; 5: 1389–45.
40. Sniecinski RM, Levy JH. Bleeding and management of coagul-opathy. Journal of Thoracic and Cardiovascular Surgery 2011; 142: 662–7.
41. Schochl H, Nienaber U, Hofer G, et al. Goal-directed coagulation management of major trauma patients using thrombo-elastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Critical Care 2010; 14: R55.
42. National Institute for Health and Care Excellence (NICE). Detecting, managing and mviscoelastometric point of care testing. NICE diagnostics guidance (DG13), 2014. https// www.nice.org.uk/Guidance/DG13 (accessed 03/09/2014).
43. Schochl H, Voelckel W, Grassetto A, Schlimp CJ. Practical application of point-of-care coagulation testing to guide treatment decisions in trauma. Journal of Trauma and Acute Care Surgery 2013; 74: 1587–98.
44. Davenport R, Brohi K. Fibrinogen depletion in trauma: early, easy to estimate and central to trauma-induced coagulopathy. Critical Care 2013; 17: 190.
45. Johansson PI. Coagulation monitoring of the bleeding trauma-tized patient. Current Opinion in Anaesthesiology 2012; 25: 235–41.
46. Schochl H, Voelckel W, Maegele M, Solomon C. Trauma-associ-ated hyperfibrinolysis. Hamostaseologie 2012; 32: 22–7.
47. Park MS, Martini WZ, Dubick MA, et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. The Journal of Trauma 2009; 67: 266–75.
48. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. Journal of Thrombosis and Haemostasis 2007; 5: 266–73.
49. Fenger-Eriksen C, Moore GW, Rangarajan S, Ingerslev J, Soren-sen B. Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expand-ers. Transfusion 2010; 50: 2571–6.
50. Hill JS, Devenie G, Powell M. Point-of-care testing of coagulation and fibrinolytic status during postpartum haemorrhage: developing a thrombelastography(R)-guided transfusion algo-rithm. Anaesthesia and Intensive Care 2012; 40: 1007–15.
51. (R) thromboelastometry. International Journal of Obstetric Anesthesia 2011; 20: 293–8.
52. Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for manage-ment. British Journal of Anaesthesia 2012; 109: 851–63.
53. Shakur H, Elbourne D, Gulmezoglu M, et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials 2010; 11: 40.
54. Kang Y. Thromboelastography in liver transplantation. Seminars in Thrombosis and Hemostasis 1995; 21(Suppl 4): 34–44.
55. Wang SC, Shieh JF, Chang KY, et al. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplantation Proceedings 2010; 42: 2590–3.
56. Massicotte L, Beaulieu D, Thibeault L, et al. Coagulation defects do not predict blood product requirements during liver transplantation. Transplantation 2008; 85: 956–62.
57. Stravitz RT. Potential applications of thromboelastography in patients with acute and chronic liver disease. Gastroenterol-ogy and Hepatology 2012; 8: 513–20.
58. Clevenger B, Mallett SV. Transfusion and coagulation management in liver transplantation. World Journal of Gastroenterol-ogy 2014; 20: 6146–58.
59. Kitchen DP, Kitchen S, Jennings I, Woods T, Walker I. Quality assurance and quality control of thrombelastography and rotational thromboelastometry: the UK NEQAS for blood coagulation experience. Seminars in Thrombosis and Hemostasis 2010; 36: 757–63.
60. Gorlinger K, Dirkmann D, Hanke AA. Potential value of transfusion protocols in cardiac surgery. Current Opinion in Anaes-thesiology 2013; 26: 230–43.
61. Agarwal S, Coakley M, Reddy K, Riddell A, Mallett S. Quantify-ing the effect of antiplatelet therapy: a comparison of the platelet function analyzer (PFA-100) and modified thrombo-elastography (mTEG) with light transmission platelet aggre-gometry. Anesthesiology 2006; 105: 676–83.
62. Rahe-Meyer N, Winterhalter M, Boden A, et al. Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry. Acta Anaes-thesiologica Scandinavica 2009; 53: 168–75.
63. Tanaka KA, Subramaniam K. II. Looking into the future of platelet transfusion in the presence of P2Y12 inhibitors. British Journal of Anaesthesia 2014; 112: 780–4.
64. Kasivisvanathan R, Abbassi-Ghadi N, Kumar S, et al. Risk of bleeding and adverse outcomes predicted by thromboelastog-raphy platelet mapping in patients taking clopidogrel within 7 days of non-cardiac surgery. British Journal of Surgery 2014; 11: 1383–90.